<?xml version="1.0" encoding="UTF-8"?>
<ref id="B207-microorganisms-07-00133">
 <label>207.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Brandler</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ruffié</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Combredet</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Brault</surname>
    <given-names>J.-B.</given-names>
   </name>
   <name>
    <surname>Najburg</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Prevost</surname>
    <given-names>M.-C.</given-names>
   </name>
   <name>
    <surname>Habel</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Tauber</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Desprès</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Tangy</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus</article-title>
  <source>Vaccine</source>
  <year>2013</year>
  <volume>31</volume>
  <fpage>3718</fpage>
  <lpage>3725</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.05.086</pub-id>
  <pub-id pub-id-type="pmid">23742993</pub-id>
 </element-citation>
</ref>
